aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Motif Neurotech develops minimally invasive bioelectronic implants designed to monitor and treat severe mental illnesses. The company's core mission is to revolutionize mental health care through advanced technology, offering innovative solutions to improve patient outcomes. Their market focus includes individuals suffering from conditions such as depression and anxiety, aiming to provide effective and less invasive treatment options.
Motif Neurotech has made significant strides in the field of bioelectronics, contributing to the advancement of mental health treatments. Their pioneering work has garnered attention from the medical community and potential investors, positioning them as a key player in the intersection of technology and mental health care.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Bioelectronic Implants
Technology
Analytics, HealthTech
Tags
Biotech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Motif Neurotech founded?
Motif Neurotech was founded in 2022.
Where is Motif Neurotech's headquarters located?
Motif Neurotech's headquarters is located in Houston, US.
When was Motif Neurotech's last funding round?
Motif Neurotech's most recent funding round was for $18.8M (USD) in January 2024.
How many employees does Motif Neurotech have?
Motif Neurotech has 6 employees as of Feb 5, 2024.
How much has Motif Neurotech raised to-date?
As of July 05, 2023, Motif Neurotech has raised a total of $18.9M (USD) since Jan 24, 2024.
Add Comparison
Total Raised to Date
$18.9M
USD
Last Update Jan 24, 2024
Last Deal Details
$18.8M
USD
Jan 24, 2024
Series A
Total Employees Over Time
6
As of Feb 2024
Motif Neurotech Address
Houston,
77009
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts